Jundong Lin

机构：Guangzhou First People's Hospital, Guangzhou Medical University · ORCID：0000-0001-7068-2172

发表论文 18 篇 · 总被引 199 次 · h-index 7

代表论文

• FKBP10 promotes clear cell renal cell carcinoma progression and regulates sensitivity to the HIF2α blockade by facilitating LDHA phosphorylation (2024 · Cell Death and Disease · 被引 59)
• Ferrocene‐Based Polymeric Nanoparticles Carrying Doxorubicin for Oncotherapeutic Combination of Chemotherapy and Ferroptosis (2022 · Small · 被引 47)
• Fluorescent Nanoparticles Achieve Efficient Photothermal Conversion and Enhanced Antitumor Efficacy Through Intermolecular Aggregation‐Caused Quenching (2024 · Aggregate · 被引 21)
• A Unique Approach: Biomimetic Graphdiyne-Based Nanoplatform to Treat Prostate Cancer by Combining Cuproptosis and Enhanced Chemodynamic Therapy (2024 · International Journal of Nanomedicine · 被引 16)
• Untargeted metabolomics reveals alterations in the metabolic reprogramming of prostate cancer cells by double-stranded DNA-modified gold nanoparticles (2022 · Biomaterials Advances · 被引 16)
• Precision targeted melanoma therapy via cuproptosis/chemodynamic and chemotherapy: An engineering MCHS-CuMOF nanodelivery system (2025 · Biomaterials Advances · 被引 10)